Naty Villasanti

Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial

R. Plummer, H. Pandha, P. Lorigan, 2018, Oncoimmunology.